Evicenter
P&T meetings

Anaphylm (dibutepinephrine)

Type I allergic reactions including anaphylaxis

Also known as AQST-109
Regulatory submission
NDA resubmitted September 2026
Launch
Not announced
Last updated
121 sources

Clinical evidence

Anaphylm temperature and pH pharmacokinetic study

10 evidence topics · 1 source

Objective
Location and study date
Study design
Eligibility criteria
Treatment
Study outcomes
Rationale for using maximum epinephrine concentration and area under the curve as the primary endpoints
Statistical analysis description
Number of participants (Planned and analyzed)
Description of analysis sets

No evidence found.

Results
Participant disposition

No evidence found.

Baseline characteristics

No evidence found.

Efficacy results
Exposure ratios by test condition relative to room temperature water
Test conditionCmax ratio to room temperature waterAUC 0-60min ratio to room temperature water
Cold water“106%”“98%”
Hot water“104%”“107%”
Lemon water (target pH: 3)“98%”“99%”
Baking soda water (target pH: 8)“123%”“132%”
Health-related quality of life and patient-reported outcomes

No evidence found.

Safety results

No evidence found.

Study limitations
Summary: study limitations

The study enrolled 30 healthy adult volunteers and tested only water at three temperatures, lemon water and baking soda water, so it does not directly address the beverages and foods that the company noted fall between these acidity extremes. Pharmacodynamic results were not available at the time of the topline release, safety results were not reported, and only ratios relative to room temperature water were published, without absolute Cmax or area under the curve values or confidence intervals. No registry record or peer-reviewed publication of the study was located.